Core Insights - The first "data intellectual property + stock option" case in China has been implemented in Suzhou, facilitating YuanShell Bio (Suzhou) Co., Ltd. to register and manage data intellectual property assets as stock options, thereby linking the long-term commercial value of data with talent incentives [1][2] - YuanShell Bio, established in 2024, focuses on organ chip technology and has developed a clear plan to address the challenges of "difficult rights confirmation and monetization" of high-value research data [1] Group 1 - The company has created a high-quality data set using neural system organ chip technology and AI image recognition algorithms, providing standardized data support for disease mechanism research, drug screening, and brain-like model construction [1] - YuanShell Bio has proactively applied for registration of data intellectual property before commercial application, obtaining multiple data intellectual property certificates, thus transforming core research data into legally protected assets [1] Group 2 - The key innovation lies in "binding data assets to stock options," where the company grants 5% equity to the core team based on registered data intellectual property, enhancing team ownership and creativity, and fostering a virtuous cycle of "data innovation - value sharing - re-innovation" [2] - The case aligns with the characteristics of technology-driven enterprises that are "light on assets, heavy on data," breaking through traditional rights confirmation and incentive models, and providing a replicable sample for innovation in data-intensive industries [2] - As of January 2026, the province has issued 4,054 data intellectual property registration certificates, ranking second nationwide, serving over 1,000 business entities across all 20 categories of the national economic classification, and achieving over 12 million yuan in registered data transaction licenses, 475 million yuan in pledge financing, and 637 million yuan in securitized products [2]